Who owns Aquestive Therapeutics Inc?
- Ticker: AQST
- CUSIP Number: 03843e104
Tip: Access positions for across all investors
Analyze quarterly positions in Aquestive Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aquestive Therapeutics stock
Who bought or sold Aquestive Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.9M | $3.8M | 11% | Dec 2023 |
|
| Essex Investment Management | 846k | $1.7M | 100% | Dec 2023 |
|
| Vahanian & Associates Financial Planning | 592k | $1.2M | -18% | Dec 2023 |
|
| Bracebridge Capital | 429k | $866k | 0% | Dec 2023 |
|
| Marshall Wace | 289k | $584k | -7% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 262k | $528k | 6% | Dec 2023 |
|
| Legato Capital Management | 249k | $1.1M | -27% | Mar 2024 |
|
| Latash Investments | 243k | $491k | 0% | Dec 2023 |
|
| CI Private Wealth | 192k | $387k | -58% | Dec 2023 |
|
| Citadel Advisors | 184k | $373k | 709% | Dec 2023 |
|
| Two Sigma Investments | 167k | $338k | 135% | Dec 2023 |
|
| Jane Street | 156k | $315k | 100% | Dec 2023 |
|
| HighTower Advisors | 131k | $265k | 0% | Dec 2023 |
|
| Millennium Management | 131k | $264k | -32% | Dec 2023 |
|
| Walleye Trading Advisors | 126k | $255k | -19% | Dec 2023 |
|
| 683 Capital Management | 94k | $189k | 100% | Dec 2023 |
|
| Citigroup | 82k | $166k | 100% | Dec 2023 |
|
| Beacon Pointe Advisors | 60k | $121k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 51k | $103k | 21352% | Dec 2023 |
|
| PFG Investments | 48k | $205k | 100% | Mar 2024 |
|
| HBK Sorce Advisory | 42k | $86k | 0% | Dec 2023 |
|
| Occudo Quantitative Strategies | 35k | $71k | -41% | Dec 2023 |
|
| Virtu Financial | 32k | $65k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 31k | $62k | 100% | Dec 2023 |
|
| Jump Financial | 30k | $60k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 27k | $54k | -11% | Dec 2023 |
|
| Financial Advocates Investment Management | 20k | $40k | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 19k | $39k | 0% | Dec 2023 |
|
| Bank Of Montreal | 19k | $39k | -3% | Dec 2023 |
|
| Raymond James Financial Services Advisors | 17k | $70k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 14k | $29k | 0% | Dec 2023 |
|
| Trust Point | 14k | $59k | 37% | Mar 2024 |
|
| Lazard Asset Management | 14k | $27k | 1664% | Dec 2023 |
|
| Bank of America Corporation | 8.7k | $18k | 100% | Dec 2023 |
|
| Dixon Mitchell Investment Counsel | 4.0k | $17k | 100% | Mar 2024 |
|
| Federated Investors | 2.4k | $4.9k | 9% | Dec 2023 |
|
| UBS Group | 2.3k | $4.6k | 100% | Dec 2023 |
|
| Richard W. Paul & Associates | 1.4k | $2.9k | 0% | Dec 2023 |
|
| Parallel Advisors | 100.00 | $202.000000 | 100% | Dec 2023 |
|
| Coppell Advisory Solutions | 16.00 | $32.000000 | -57% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 1.00 | $2.000000 | 0% | Dec 2023 |
|
Who sold out of Aquestive Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| GSA Capital Partners | Sep 2023 | 101k | $154k |
| Squarepoint Ops | Sep 2023 | 76k | $116k |
| Man Group | Sep 2023 | 44k | $67k |
| Bank of New York Mellon | Dec 2023 | 15k | $30k |
| Heron Bay Capital Management | Sep 2023 | 14k | $22k |
| D.B. Root & Company | Dec 2023 | 12k | $23k |
| Barclays | Sep 2023 | 7.1k | $11k |